Donga ST received approval of superbacteria antibiotics 'Tedizolid' from the U.S. FDA
On June 22, Donga ST announced that they received approval of 'Tedizolid (tedizolid phosphate)' from the U.S. FDA. Donga ST had exported techniques of superbacteria target antibiotics 'Tedizolid' to Trius Therapeutics. The U.S. plans to complete product packaging soon, and launch the new drug wit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
